Standout Papers
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. (1996)
- Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update (2017)
- American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003 (2003)
- American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care (2012)
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline (2014)
- American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer (2009)
- Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer (2004)
- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update (2015)
- High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190 (2000)
- 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines (2000)
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update (2020)
- Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update (2015)
- Hospital and Physician Volume or Specialization and Outcomes in Cancer Treatment: Importance in Quality of Cancer Care (2000)
- American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)
- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update (2017)
- American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology (2012)
- American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer (2011)
- Management of Cancer Cachexia: ASCO Guideline (2020)
- Unmet supportive care needs of people with advanced cancer and their caregivers: A systematic scoping review (2022)
Immediate Impact
4 by Nobel laureates 7 from Science/Nature 88 standout
Citing Papers
Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
Ponsegromab for the Treatment of Cancer Cachexia
2024 Standout
Works of Thomas J. Smith being referenced
Cancer Cachexia: ASCO Guideline Rapid Recommendation Update
2023
Management of Cancer Cachexia: ASCO Guideline
2020 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas J. Smith | 8731 | 15539 | 4522 | 6971 | 687 | 35.3k | |
| Richard Doll | 8630 | 10911 | 2055 | 7150 | 391 | 48.9k | |
| Frank E. Speizer | 12485 | 7717 | 2670 | 7713 | 331 | 62.2k | |
| Leslie Bernstein | 5682 | 16855 | 3349 | 5403 | 618 | 39.7k | |
| J.W.W. Coebergh | 2821 | 16020 | 2233 | 6224 | 519 | 29.8k | |
| Alfred I. Neugut | 2755 | 12140 | 1602 | 6238 | 666 | 30.3k | |
| Hans‐Olov Adami | 5579 | 16455 | 2538 | 9457 | 661 | 47.1k | |
| Donna Spiegelman | 15915 | 6314 | 5277 | 2483 | 623 | 53.3k | |
| Hermann Brenner | 5574 | 23237 | 3746 | 12002 | 1.5k | 62.7k | |
| Charles F. Lynch | 3385 | 7913 | 2379 | 3887 | 429 | 26.9k | |
| Eero Pukkala | 4019 | 10570 | 2255 | 6660 | 724 | 37.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...